Cadila Healthcare Limited has informed the Exchange regarding a press release dated August 05, 2020, titled " Zydus Cadila announces Completion of Dosing in Phase I Clinical Trial of ZyCov-D .".
Press Release Aug 05 2020
Filed with NSE ·
6ix hasn’t read this filing yet.
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
Later from Zydus Lifesciences
- Press Release Aug 13 2020
- Press Release Sep 02 2020
- Press Release Sep 03 2020
- Press Release Sep 09 2020
- Press Release Sep 11 2020
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences